Global Point of Care (POC) Diagnostics Market Report 2015 - Forecasts to 2019

Nov 03, 2015, 13:10 ET from Research and Markets

DUBLIN, Nov. 3, 2015 /PRNewswire/ -- Research and Markets ( has announced the addition of the "The World Market for Point of Care (POC) Diagnostics" report to their offering.

Diagnostic tests performed outside the central laboratory or decentralized testing are generally known as point of care (POC) tests. The increasing introduction of transportable, portable, and handheld instruments has resulted in the migration of POC testing from the hospital environment to a range of medical environments including the workplace, home, disaster care and most recently, convenience clinics. 

Who are the top companies in the market? What types of point of care testing is selling fastest?  What disease areas will drive near-patient forward?  Is POC earning its place in clinical practice?  How is home testing progressing?   The World Market for Point of Care (POC) Diagnostics presents current analysis of the POC diagnostics industry and the role it plays in medical practice. This report takes an in-depth look at the POC diagnostic testing market, both professional and self-testing.

The report provides data on the size and growth of the following POC market segments:

  • Blood Glucose Tests
  • Blood and Electrolytes Testing Market
  • Rapid Coagulation
  • Rapid Cardiac Markers
  • Substance Abuse Testing
  • Pregnancy and Fertility Testing
  • Colon Cancer Screening/Fecal Occult Blood Testing
  • Infectious Disease Testing
  • Cholesterol Testing
  • Cancer Testing
  • Urine Strip Testing
  • Miscellaneous POC Testing

The menu for point-of-care testing continues to expand. The traditional set of POC tests includes: blood glucose testing, blood gas and electrolytes analysis, rapid coagulation testing, rapid cardiac markers diagnostics, drugs of abuse screening, urine strips testing, pregnancy testing, fecal occult blood analysis, hemoglobin diagnostics, infectious disease testing and cholesterol screening. In the past 5-10 years the following tests were added: HgA1c, B-Type Natriuretic Peptide (BNP), whole-blood lactate, D-Dimer, C-Reactive Protein (CRP). 

POC test devices have contributed significantly to the growth of the overall diagnostics market over the past 10 years. POC testing appears to be headed for an even bigger role in diagnosis and monitoring patient care. New technologies are allowing POC devices to produce quantitative lab-quality test results that can be transferred automatically to an information system, a remote caregiver service for consultation or an electronic medical record. 

The forecasted market analysis for 2014-2019 is largely based on demographic trends, new developments, innovative technology and global expansion.

Market analysis of the global POC testing market includes

  • Market Overview
  • Market Analysis by Product Categories
  • Market Analysis by Subcategory: POC Professional Testing, POC Self-Testing
  • Market Analysis by Country: United States, Germany, France, UK, Switzerland, Japan, China, India
  • Market Conclusions
  • Competitive Analysis
  • The World Market for Point of Care (POC) Diagnostics presents the main issues and trends affecting this market, influencing its move into the future. These include:
  • Reimbursement Challenges
  • Competition
  • POC and Biosensors
  • POC Connectivity
  • The Emergence of Non-invasive Technologies

Among the top and/or innovative competitors discussed within the report's Corporate Profiles are:

  • Abaxis
  • Abbott Labs
  • Accriva
  • ACON
  • Alere
  • Arkray
  • Beckman Coulter
  • bioMerieux SA
  • Church & Dwight
  • Eiken Chemical
  • EKF Diagnostics
  • Enterix
  • Helena Labs
  • Insight Pharmaceutical
  • Instrumentation Laboratories
  • LifeScan
  • Macherey-Nagel
  • Meridian BioScience
  • Nova Biomedical
  • OPKO Health
  • OraSure
  • Ortho Clinical Diagnostics
  • Polymed Therapeutics
  • Polymer Technologies
  • Quidel
  • Radiometer Medical
  • Response Biomedical
  • Roche Diagnostics
  • Siemens Healthcare
  • Sysmex
  • Trinity Biotech

For more information visit

Media Contact:

Laura Wood, +353-1-481-1716,


SOURCE Research and Markets